The Fatty Kidney: Obesity and Renal Disease
- PMID: 27414023
- DOI: 10.1159/000447674
The Fatty Kidney: Obesity and Renal Disease
Abstract
Obesity-related glomerulopathy (ORG) is characterized by glomerulomegaly accompanied in many patients by lesions of focal and segmental glomerulosclerosis. Slowly increasing subnephrotic proteinuria is the commonest presentation of ORG. Occasionally, massive proteinuria (>5-10 g/day) is detected, but the typical findings of nephrotic syndrome are characteristically absent even in patients with massive proteinuria. Superimposed obesity can fuel the progression of other renal diseases, and a reduced number of functioning nephrons (of congenital or acquired causes) synergizes with obesity to induce end-stage renal disease. Weight loss, either induced by diet or bariatric surgery, and renin-angiotensin blockers are effective treatments to slow progression, but a significant proportion of cases will develop end-stage renal disease.
Keywords: Angiotensin-converting enzyme inhibitors; Focal and segmental glomerulosclerosis; Hyperfiltration.
© 2016 S. Karger AG, Basel.
Similar articles
-
Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.Front Med. 2017 Sep;11(3):340-348. doi: 10.1007/s11684-017-0570-3. Epub 2017 Aug 8. Front Med. 2017. PMID: 28791668 Review.
-
Obesity-related glomerulopathy: an emerging epidemic.Kidney Int. 2001 Apr;59(4):1498-509. doi: 10.1046/j.1523-1755.2001.0590041498.x. Kidney Int. 2001. PMID: 11260414
-
The Fatty Kidney and Beyond: A Silent Epidemic.Am J Med. 2023 Oct;136(10):965-974. doi: 10.1016/j.amjmed.2023.06.025. Epub 2023 Jul 13. Am J Med. 2023. PMID: 37451390 Review.
-
Renal disease in obesity: the need for greater attention.J Ren Nutr. 2006 Jul;16(3):216-23. doi: 10.1053/j.jrn.2006.04.017. J Ren Nutr. 2006. PMID: 16825023 Review.
-
Which Patients with Obesity Are at Risk for Renal Disease?Nephron. 2021;145(6):595-603. doi: 10.1159/000513868. Epub 2021 Mar 5. Nephron. 2021. PMID: 33677441 Review.
Cited by
-
Visceral fat and attribute-based medicine in chronic kidney disease.Front Endocrinol (Lausanne). 2023 Feb 9;14:1097596. doi: 10.3389/fendo.2023.1097596. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843595 Free PMC article. Review.
-
Obesity Related Metabolic Disorders and Risk of Renal Disease: Impact of Hypocaloric Diet and Avena Sativa Supplement.Open Access Maced J Med Sci. 2018 Jul 29;6(8):1376-1381. doi: 10.3889/oamjms.2018.292. eCollection 2018 Aug 20. Open Access Maced J Med Sci. 2018. PMID: 30159060 Free PMC article.
-
Bariatric Surgery Outcomes in Patients with Chronic Kidney Disease.J Clin Med. 2023 Sep 21;12(18):6095. doi: 10.3390/jcm12186095. J Clin Med. 2023. PMID: 37763037 Free PMC article.
-
Exploring the link between kidney dimensions and anthropometric measurements: insights from a Saudi population study.Arch Med Sci Atheroscler Dis. 2024 Sep 25;9:e171-e176. doi: 10.5114/amsad/192995. eCollection 2024. Arch Med Sci Atheroscler Dis. 2024. PMID: 39559175 Free PMC article.
-
Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients.Obes Facts. 2019;12(3):357-368. doi: 10.1159/000500360. Epub 2019 Jun 5. Obes Facts. 2019. PMID: 31167211 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical